Wellness
Rituals, cosmetics and non-food uses of hemp: what the French framework allows a seller to write, and what it forbids them to promise.
Wellness
Wellness16 September 2026·9 min
CBD massage oil: reading the label in 6 points
A CBD massage oil is a cosmetic. The INCI list, the EU benchmark of 0.19%, fragrance allergens since July 2026, the elbow-crease test and storage, explained plainly.
Wellness21 July 2026·7 min
CBD and fibromyalgia: what a 200-patient trial found
A 24-week trial of 200 patients found 50 mg of CBD a day no better than a placebo on pain. What research shows, and what the French health authority says.
Wellness21 July 2026·8 min
Is CBD an aphrodisiac? No human trial, one test in mice
No human trial has measured the effect of CBD on libido. The only direct test, in male mice, found less sexual activity and lower fertility.
Wellness13 July 2026·7 min
CBD to quit smoking: what 3 studies actually show
Three studies, 74 smokers, a few days of follow-up: what research has measured on CBD and tobacco, set against nicotine replacement therapy.
Wellness13 July 2026·7 min
CBD and hot flushes: no trial published to date
No published trial has tested CBD against menopausal hot flushes. What a rat study, two surveys of women and French law actually show on the question.
Wellness13 July 2026·7 min
CBD and migraine: what the first controlled trial found
In a 2026 trial, 92 adults treated migraine attacks with CBD, THC, a blend or placebo. At two hours, CBD alone did no better than placebo.
Wellness5 June 2026·8 min
CBD and endometriosis: what the placebo trial showed
In a 2026 trial of 102 women, CBD did no better than placebo on endometriosis pain. The results, their limits, and the trials still running.
Wellness5 June 2026·8 min
CBD and the liver: what blood tests show, dose by dose
CBD and liver enzymes: 0.36% clear anomalies around 50 mg a day, 5.6% at 5 mg/kg, 15% on high-dose Epidyolex. The bigger issue is drug interactions.
Wellness18 May 2026·7 min
Brain fog and CBD: what the science allows us to say
Brain fog is a complaint without a diagnosis. CBD trials give healthy volunteers 150 to 600 mg and find no memory gain. Causes, doses tested and French rules.
Wellness18 May 2026·8 min
CBD and sleep: what the trials show, dose by dose
For insomnia, 150 mg of CBD a night did no better than a placebo. The trials, their doses set against EFSA's 2 mg reference, and the advice of health authorities.
Wellness18 May 2026·7 min
CBD for older people: precautions and gaps in the studies
CBD after 65: interactions with treatments, drowsiness, the liver, the limits of trials, what is still sold in France, and what to check with your pharmacist.
Wellness18 May 2026·10 min
CBD and stress: trials used up to 300 times the EFSA dose
France allows no stress-relief claim for CBD. Anxiety trials tested 150 to 600 mg, far above the 2 mg a day EFSA takes as a provisional safe level.
Wellness16 May 2026·8 min
Alcohol or cannabis: which is more harmful? The numbers
On deaths, dependence and toxicity, alcohol outweighs cannabis on almost every measure. Combined, the two multiply the risk of a fatal crash by 29.
Wellness16 May 2026·9 min
CBD and osteoarthritis: two placebo trials, no difference
Two placebo-controlled trials of CBD in osteoarthritis, 222 patients, no measurable difference. What a CBD balm is worth and what French guidance recommends.
Wellness16 May 2026·6 min
CBD and yoga: no studies, but the timing is worth knowing
CBD has never been tested on yoga or meditation. Its blood peak is known, though: 3 minutes after inhaling, and one to five hours when taken by mouth.
Wellness16 May 2026·6 min
CBD and appetite: trials point to a decrease
Unlike THC, CBD does not cause hunger, and high-dose trials mostly report reduced appetite. The figures, doses and limitations, and the legal framework in France.
Wellness16 May 2026·8 min
CBD and the prostate: one human trial, and its limits
CBD has no approved use for the prostate. The one human trial, with 21 men taking 800 mg a day, measured tolerability. What the studies show, and where they stop.
Wellness16 May 2026·7 min
Cannabis, CBD and pain: what the trials show
In trials, CBD did no better than placebo against pain. What the 2026 Cochrane review, medical cannabis in France and the law on product claims actually say.
Wellness16 May 2026·8 min
Tobacco vs cannabis: two dependencies, one kind of smoke
Nicotine or THC: two plants, two kinds of dependence, and smoke carrying similar toxicants. What the studies measure, and why a French joint usually holds both.
Wellness12 May 2026·8 min
CBD and melatonin: two mechanisms, no joint trial
Melatonin sets the body clock; CBD acts elsewhere. No human trial has tested the two together, and gummies combining them cannot legally be sold in France.
Wellness12 May 2026·8 min
CBD for PMS and period pain: what the studies say
No controlled trial of CBD for PMS or period pain has published results. What the surveys actually measure, what French law permits and when you should see a doctor.